https://www.avient.com/resources/safety-data-sheets?page=1814
OFF WHITE 2
GE BLACK PC
GE GRAY PC
https://www.avient.com/resources/safety-data-sheets?page=3892
95182 ABS WHITE EHI
SOFT LIME PC 2
TRANS RED PC 192C
https://www.avient.com/sites/default/files/2021-09/mevopur-colors-and-additives-for-ivd-devices-application-bulletin-cn.pdf
功能 目标应用 血液采集 试剂容器/试剂盒
移液器/
器具 设备/配件
即用型配方避免对分析测试的干扰;
可萃取金属数据
聚合物对激光能量的激活可提供高
对比度、无溶剂的
高速鉴别
定制母粒和即用型配方可提供
透明和不透明颜色,同时允许激光
传输/吸收
PE和PP的新一代快速成核剂;提
高尺寸稳定性,热性能和机械性能
降低湿蒸汽透过率(MVTR)
HDPE即用型配方
吸湿母粒
减少 BCT(血液收集管)中因氧传
输造成的真空损失,并保护试剂免
受氧化降解
在290-450nm波长范围内阻挡紫
外线,对透明度没有影响;保护光
敏试剂
自检/即时检验
(POCT)
用于实验室自动化/
鉴别编码的着色剂
颜色—低迁移/减
低干扰
颜色—生物相容
性评估
透明PP
PP、ABS、
PC/ABS的抗静电
性能
激光焊接可
快速、可靠地组装
一系列聚合物
半结晶聚合物
的成核剂,例如
HDPE、PP、POM
防止氧气进入的
PET吸氧剂
透明容器(PP、
PE、PETG、COP)
中的紫外光防护
防潮以改善屏障
激光打标的UDI替
代油墨印刷/贴标
PP、ABS、PC和
高温聚合物的颜
色,符合UL认证
为各种聚合物提供多种颜色,能够
为您的工艺提供适用的即用型配方
或母粒
降低不符合现行和拟定法规(如
IVDR)的风险
即用型解决方案/母粒支持针对电器
外壳的UL要求
永久性/非迁移性即用型配方;不受
相对湿度(%)影响的快速静电衰
减时间
不含山梨醇,最大限度地减少潜在
迁移
1.844.4AVIENT
www.avient.com
版权所有© 2021埃万特公司。
https://www.avient.com/investor-center/news/avient-appoints-ashish-k-khandpur-chief-executive-officer-effective-december-1-2023
He has since led several different 3M businesses, most recently serving as Group President of 3M's Transportation and Electronics Business.
Light-weighting solutions that replace heavier traditional materials like metal, glass and wood, which improves fuel efficiency in all modes of transportation and reduces the carbon footprint
https://www.avient.com/idea/counterfeiting-how-fight-back
Within these two areas, there are a handful of different application methods used to incorporate a security authentication solution into a product.
When viewed under a black light or other illumination technology, the unique identification in the ink or dye is revealed.
https://www.avient.com/resources/safety-data-sheets?page=5575
TL WHITE DIF PC 2X
TL WHITE DIF.
PC .5
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-earnings-presentation_0.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which
could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues;
• Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Color business, including any expected synergies;
• Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Our ability to consummate and successfully integrate acquisitions;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.”
D
is
t.
)
K
W
R
P
P
G
A
V
Y
F
U
L
R
P
M
G
C
P
F
M
C
H
X
L
H
U
N
E
C
L
A
S
H
E
M
N
C
E
S
C
L
Source: Peer data per Bloomberg market data as of October 25, 2021
Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M)
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
Free Cash Flow Conversion (1)
2021E (%)
Being asset light helps us to generate
strong free cash flow that is in line
with specialty formulators.
https://www.avient.com/sites/default/files/2021-04/avnt-first-quarter-2021-news-release.pdf
Patterson added, “We are an asset-light, high-touch business that generates very high free
cash flow conversion.
Examples include:
• Barrier technologies that preserve the shelf-life and quality of food, beverages, medicine
and other perishable goods through high-performance materials that require less plastic
• Light-weighting solutions that replace heavier traditional materials like metal, glass and
wood, which can improve fuel efficiency in all modes of transportation
• Breakthrough technologies that minimize wastewater and improve the recyclability of
materials and packaging across a spectrum of end uses
Avient employs approximately 8,400 associates and is certified ACC Responsible Care®, a
founding member of the Alliance to End Plastic Waste and certified Great Place to Work®.
They are based on management's
expectations that involve a number of business risks and uncertainties, any of which could cause
actual results to differ materially from those expressed in or implied by the forward-looking
statements.
https://www.avient.com/investor-center/news/avient-provides-fourth-quarter-2020-updates
Light-weighting solutions that replace heavier traditional materials like metal, glass and wood, which can improve fuel efficiency in all modes of transportation
They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to continue to pay cash dividends including at the increased rate; the amount and timing of share repurchases, if any; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/trilliant-hc-healthcare-thermoplastics
These customizable formulations can replace traditional materials such as FR PC/ABS, FR PC/PET and FR COPE, offer improved chemical resistance to common disinfectants, achieve a UL 94 V-0 at 1.5 & V-1 at 0.75 flame rating when necessary, and can often be molded in existing PC/ABS tooling.
Outperforms FR PC/ABS, FR PC/PET and FR COPE in resistance to common disinfectants
White Paper